Risk factors associated with venous thromboembolism in breast cancer: a narrative review

ZA Razouki, NT Ali, VQ Nguyen… - Supportive Care in Cancer, 2022 - Springer
Purpose To date, there is no universally acceptable risk assessment tool in clinical practice
that accurately estimates the risk of venous thromboembolism (VTE) in patients with breast …

[HTML][HTML] Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review

K Curtis, K Gough, M Krishnasamy, E Tarasenko, G Hill… - BMC cancer, 2024 - Springer
Background Lack of agreed terminology and definitions in healthcare compromises
communication, patient safety, optimal management of adverse events, and research …

A novel oncotherapy strategy: Direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non‐small cell lung cancer

B Zhao, M Wu, Z Hu, T Wang, J Yu, Y Ma… - British Journal of …, 2022 - Wiley Online Library
Background and Purpose Cancer cachexia and cancer‐associated thrombosis are
potentially fatal outcomes of advanced cancer. Nevertheless, thrombin expression in non …

No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a Mendelian randomization study

Q Qin, Y Pan, L Wang - Journal of Thrombosis and Thrombolysis, 2024 - Springer
Active cancer is known to contribute to venous thromboembolism (VTE), but the cause-and-
effect association of breast cancer on VTE is not yet clear. In order to investigate the possible …

[HTML][HTML] Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period

L Liu, Z Liu, J Wang, M Cheng, Y Xie, W Wang, C Ma… - Scientific Reports, 2023 - nature.com
Totally implantable venous access devices (TIVADs) have been widely used for many years
in the management of patients suffering from cancer. Thrombotic occlusion is the most …

[HTML][HTML] Development and validation of a new clinical prediction model of catheter-related thrombosis based on vascular ultrasound diagnosis in cancer patients

B Liu, J Xie, X Sun, Y Wang, Z Yuan, X Liu… - Frontiers in …, 2020 - frontiersin.org
Background: Central venous catheters are convenient for drug delivery and improved
comfort for cancer patients, but they also cause serious complications. The most common …

Evaluation of stability of deep venous thrombosis of the lower extremities using Doppler ultrasound

S Zhang, W Chu, H Wang, Y Liang… - Journal of …, 2020 - journals.sagepub.com
Objective This study aimed to assess using Doppler ultrasound for analyzing stability of
deep venous thrombosis (DVT) of the lower extremities. Methods Patients with DVT of the …

从肿瘤心脏病学探讨恶性肿瘤与心血管疾病及药物干预相关性研究进展

刘少烽, 莫思燕, 黄世香, 吴家恩 - 中国肿瘤临床, 2019 - cqvip.com
恶性肿瘤与心血管疾病具有多项共同危险因素, 许多抗肿瘤治疗方案具有潜在心血管毒性,
日益成为影响这类疾病预后的关键因素. 目前, 国际上对于肿瘤心脏病学的研究主要围绕恶性 …

[HTML][HTML] A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer

X Song, S Chen, Y Dai, Y Sun, X Lin, J He… - World Journal of Surgical …, 2023 - Springer
Background A totally implanted venous access port (TIVAP) in the upper arm is a safe and
cost-effective vascular access device and is widely used in breast cancer patients …

[HTML][HTML] Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for …

Y Wang, H Tian, X Chen, J Zhang, L Wang… - Frontiers in …, 2022 - frontiersin.org
Aim To investigate the safety and feasibility of extending the flushing interval for the totally
implantable venous access port (TIVAP) during the non-treatment stage in patients with …